NEU 0.15% $13.13 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-538

  1. 1,255 Posts.
    lightbulb Created with Sketch. 317
    I would not be super happy if the partner is Acadia again this time. While they have done well with Retts, they lack the financial strength to realise the full potential of trofinetide alone not to mention the much bigger opportunities with NZ2561. Fragile x is phase 3 ready through Trofinetide but they have been sitting it
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.